Retraction Note to: IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation (Radiation Oncology, (2015), 10, (227), 10.1186/s13014-015-0534-1);IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation

Radiation Oncology

Volumn 10, Issue 1, 2015, Pages

  Chen, Yuhchyau ^a   Zhang, Fuquan ^a   Tsai, Ying ^a   Yang, Xiadong ^a   Yang, Li ^a   Duan, Shanzhou ^a   Wang, Xin ^a   Keng, Peter ^a   Lee, Soo Ok ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

DNA repair; IL 6; Non small cell lung cancer; Radioresistance; Stem cells

Indexed keywords

CD133 ANTIGEN; INTERLEUKIN 6; GLYCOPROTEIN; IL6 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PEPTIDE; PROM1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL RENEWAL; CELL SURVIVAL; CENTRIFUGATION; CLONOGENESIS; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IONIZING RADIATION; LUNG CANCER; MOLECULAR DYNAMICS; PLASMID; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CANCER STEM CELL; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; GENETIC TRANSDUCTION; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AC133 ANTIGEN; ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; COMET ASSAY; DNA REPAIR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS; PEPTIDES; RADIATION TOLERANCE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 84963600730     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/s13014-022-02030-5     Document Type: Erratum

References (28)

1. Cersosimo RJ. Lung cancer: a review. Am J Health Syst Pharm. 2002;59(7):611-42. PubMed Epub 2002/04/12. eng.
2. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569. PubMed Pubmed Central PMCID: 2809841, Epub 2010/01/23. eng.
3. Akunuru S, James Zhai Q, Zheng Y. Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell death & disease. 2012;3, e352. PubMed Pubmed Central PMCID: 3406592.
4. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009;106(38):16281-6. PubMed Pubmed Central PMCID: 2741477.
5. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15(3):504-14. PubMed Epub 2007/12/01. eng.
6. Wang S, Xu ZY, Wang LF, Su W. CD133+ cancer stem cells in lung cancer. Front Biosci. 2013;18:447-53. PubMed.
7. Hittelman WN, Liao Y, Wang L, Milas L. Are cancer stem cells radioresistant? Future Oncol. 2010;6(10):1563-76. PubMed Pubmed Central PMCID: 3059151.
8. Zhang X, Komaki R, Wang L, Fang B, Chang JY. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerasespecific oncolytic adenovirus. Clin Cancer Res. 2008;14(9):2813-23. PubMed Pubmed Central PMCID: 2387204.
9. Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, Gibson M, et al. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer. 2013;12(1):94. PubMed Pubmed Central PMCID: 3751356.
10. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;8(7):545-54. PubMed.
11. Liu SC, Tsang NM, Chiang WC, Chang KP, Hsueh C, Liang Y, et al. Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest. 2013;123(12):5269-83. PubMed Pubmed Central PMCID: 3859424.
12. Voboril R, Weberova-Voborilova J. Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-kappaB. Neoplasma. 2007;54(6):495-502. PubMed.
13. Zhou W, Jiang Z, Li X, Xu Y, Shao Z. Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation. J Cancer Res Clin Oncol. 2015;141(4):575-89. PubMed.
14. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315-9. PubMed.
15. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184-91. PubMed.
16. Piao LS, Hur W, Kim TK, Hong SW, Kim SW, Choi JE, et al. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett. 2012;315(2):129-37. PubMed.
17. Kitagawa R, Kastan MB. The ATM-dependent DNA damage signaling pathway. Cold Spring Harb Symp Quant Biol. 2005;70:99-109. PubMed.
18. Desai A, Webb B, Gerson SL. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells. Radiother Oncol. 2014;110(3):538-45. PubMed Pubmed Central PMCID: 4004669.
19. Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells. 2010;28(4):639-48. PubMed Pubmed Central PMCID: 2940232.
20. Mathews LA, Cabarcas SM, Farrar WL. DNA repair: the culprit for tumorinitiating cell survival? Cancer Metastasis Rev. 2011;30(2):185-97. PubMed Pubmed Central PMCID: 3078299.
21. Rycaj K, Tang DG. Cancer stem cells and radioresistance. Int J Radiat Biol. 2014;90(8):615-21. PubMed Pubmed Central PMCID: 4341971.
22. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756-60. PubMed.
23. Ettl T, Viale-Bouroncle S, Hautmann MG, Gosau M, Kolbl O, Reichert TE, et al. AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines. Oral Oncol. 2015;51(2):158-63. PubMed.
24. Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, et al. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem cell reports. 2015;4(2):226-38. PubMed Pubmed Central PMCID: 4325196.
25. Neta R, Perlstein R, Vogel SN, Ledney GD, Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med. 1992;175(3):689-94. PubMed Pubmed Central PMCID: 2119144.
26. Wu CT, Chen MF, Chen WC, Hsieh CC. The role of IL-6 in the radiation response of prostate cancer. Radiat Oncol. 2013;8:159. PubMed Pubmed Central PMCID: 3717100.
27. Yan HQ, Huang XB, Ke SZ, Jiang YN, Zhang YH, Wang YN, et al. Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation. Cancer Sci. 2014;105(9):1220-7. PubMed.
28. Hein AL, Ouellette MM, Yan Y. Radiation-induced signaling pathways that promote cancer cell survival (review). Int J Oncol. 2014;45(5):1813-9. PubMed Pubmed Central PMCID: 4203326.